Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Miscellaneous Human Cell Lines
CFPAC-1
CFPAC-1 from ATCC
Be the first to write a review!
Citations:
(118)
Supplier Page
Supplier Page from
ATCC for
CFPAC-1
Request Info
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
CFPAC-1
Company
ATCC
Price
$431.00
Supplier Page
View Company Product Page
Catalog Number
CRL-1918
Type
Cell Biology
Species
Homo sapiens
Tissue
Pancreas
Cell Line
CFPAC-1
Validated Species Reactivity
Human (Hu)
Tissue (standardized)
Pancreas
Cell Type
epithelial cell
Age
26 years
Disease
Cystic Fibrosis Ductal Adenocarcinoma
Applications
This cell line is a suitable transfection host
Specifications/Features
Post freeze viability ≥ 50%
Add to Compare List
ATCC
10801 University Boulevard
Manassas
,
Virginia
20110-2209
United States
Phone
: (703) 365-2700
Fax: (703) 365-2701
Company Profile
Website:
http://www.atcc.org
Citations (118)
(1)
Targeting ADAR1 p150 triggers tumor inhibition and antitumor immunity to overcome immunotherapy resistance
iScience
June 19, 2026
Zhichao(Eric) Ai, Yuying Bian, Gang Li, Xiaobin S. Wang, Sining Zhu, Yumeng Li, Xiangyu Yao, Zhipeng Yan
CAL 27
,
ATCC
,
CRL-2095
Human
:
HT-29
,
ATCC
,
HTB-38
Human
:
PLC/PRF/5
,
ATCC
,
CRL-8024
Human
:
CFPAC-1
,
ATCC
,
CRL-1918
Human
: OE33,ATCC,CRL-2110
Human
: SW1990,
ATCC
,
CRL-2172
Human
:
HPAF-II
,
ATCC
,
CRL-1997
,,
Experimental models
(2)
Non-Glycosylated, Legumain-Cleavable ISACs Drive Potent Anti-Tumor Immunotherapy via a Bystander Effect
Molecular Cancer Therapeutics
April 2, 2026
Anqi Zhang, Mohan Reddy Mullapudi, Lina Wu, Michele Yi, Mohammad Asikur Rahman, Aiman A. Yaseen, H. Kayla Zhong, Tracy A. Brooks, L. Nathan Tumey
subsequently incubated for 2 days in
tumor
cell–conditioned medium collected from CFPAC-1 cells (
ATCC
, cat. #
CRL-1918
, RRID: CVCL_1119). Mouse bone marrow–derived
macrophages
(BMDM; mixed gender) were prepared following
(3)
The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer
Mol Cell
April 2, 2026
Maimon E. Hubbi, Catherine L. Wang, Yasir Suhail, Nadia L. Almasri, Jane Xie, Erin E. Hollander, Kshitiz, Alexander Muir, Ben Z. Stanger, Chi V. Dang
paper,N/A
Human
:
AsPC-1
,
ATCC
,Cat#
CRL-1682
Human
: SW1990,
ATCC
,Cat#
CRL-2172
Human
:
CFPAC-1
,
ATCC
,Cat#
CRL-1918
Human
:
BxPC-3
,
ATCC
,Cat#
CRL-1687
Human
: RCC4,Laboratory of Celeste Simon,N/A
Mouse
: 6694,Laboratory
(4)
Copper deprivation reprograms antioxidant defense to suppress ferroptosis via SLC7A11
Redox Biol
March 19, 2026
Qian Xue, Ziyuan Chen, Jiao Yang, Kaixuan Ren, Xiaofen Li, Xi Chen, Ding Yan, Yuan Wang, Daolin Tang, Jinbao Liu,
et al.
SW579, and OS-RC-2 cell lines were obtained from the American Type Culture Collection (
ATCC
;
CRL-1682
,
CRL-1918
,
CRM-CRL-1420
,
CRL-2172
, CL-0586, CL-0845, CL-0224, CL-0177). Cells were cultured in Dulbecco's Modified
(5)
Substitution Kinetics, DNA/BSA Interactions, Cytotoxicity Evaluation and Computational Analysis of [bis-(azaaryl)amine)Pt(II)/Pd(II)Cl] Complexes, Azaaryl = Quinoline or Phenanthridine
Bioinorg Chem Appl
March 4, 2026
Phakamani C. Dlamini, Thato T. Medupe, Lucy W. Macharia, Karabo Serala, Sharon Prince, Gregory S. Smith, Irvin N. Booysen, Allen Mambanda
breast MCF‐7 (
HTB‐22
),
T‐47D
(
HTB‐133
),
MDA‐MB‐231
(
CRM‐HTB‐26
), pancreatic
PANC‐1
(
CRL‐1469
),
CFPAC‐1
(
CRL‐1918
), cervical CaSki (
CRL‐1550
) and HeLa (CRM‐CCL‐2)
cancer
cells. The key aryl halide/amine precursors
(6)
Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Preclinical Pancreatic Cancer Models
Oncology Research
February 24, 2026
Pauline Gousseau, Laurie Genest, Guillaume Froget, Tristan Rupp
derived from liver
metastases
from a patient with
cystic fibrosis
[37] and was obtained from the
ATCC
(
CRL-1918
™, Manassas, Virginia, USA).
PANC-1
were isolated from a PDAC [38] and were obtained from the
ATCC
(
CRL-1469
™).
(7)
CMTM6-Silencing Microbial Immunotherapy Reprograms PDAC Tumors and Restores T-cell Function
bioRxiv
February 1, 2026
C Y Chabu, R Kazmierczak, M Hasani, N Patterson, Q Wang, L Canti, M.Z Tesfay, A Cios, B Dhagat, M.Q Pastor,
et al.
pancreatic ductal epithelial control cells (HPNE) and
pancreatic cancer
cells (CFAC-1/ ATCC Catalog#
CRL-1918
, PANC1/
ATCC
catalog#
CRL-1469
, KPC/
Kerafast
catalog#
EUP012-FP
) were grown to 80–90% confluency in 6-well
(8)
Dimensional Priming Reprograms Adipose-Derived Stromal Cells to Promote Pancreatic Cancer Progression
Cancers (Basel)
January 30, 2026
Bo Han, Zhi Yang, Shuqing Zhao, Thomas Schmittgen, Jamel Ali, Ba Xuan Hoang
gelatin hydrogel (Col-Tgel) [14,15] for 7 days unless otherwise noted.
Pancreatic cancer
CFPAC-1 cells (
CRL-1918
,
ATCC
, Manassas, VA, USA) were cultured in RPMI supplemented with 10% FBS and 1% penicillin–streptomycin. 2.2.
(9)
Nonglycosylated, Legumain-Cleavable ISACs Drive Potent Antitumor Immunotherapy via a Bystander Effect
Mol Cancer Ther
December 30, 2025
Anqi Zhang, Mohan Reddy Mullapudi, Lina Wu, Michele Yi, Mohammad Asikur Rahman, Aiman A. Yaseen, H. Kayla Zhong, Tracy A. Brooks, L. Nathan Tumey
subsequently incubated for 2 days in
tumor
cell–conditioned medium collected from CFPAC-1 cells (
ATCC
, cat. #
CRL-1918
, RRID: CVCL_1119). Mouse bone marrow–derived
macrophages
(BMDM; mixed gender) were prepared following
(10)
Systematic evaluation of GAPs and GEFs identifies a targetable dependency for hematopoietic malignancies
Cancer Discov
December 2, 2025
Pu Zhang, Zhendong Cao, Xiangyu Pan, Yuqiao Liu, Cynthia Castro, Won Jun Kim, Takeshi Fujino, Jennifer Lewis, Jahan Rahman, Sanam Shahid,
et al.
OPM1,DSMZ,RRID:CVCL_5210
Human
:
A549
,
ATCC
,
CCL-185
Human
: A375,
ATCC
,
CRL-1619
Human
: AsPC1,
ATCC
,
CRL-1682
Human
: CfPAC1,
ATCC
,
CRL-1918
Human
: MA9.3-ITD,Laboratory of James C. Mulloy,N/A
Human
: MA9.3-RAS,Laboratory of James C. Mulloy,N/A Human:
(11)
Systematic Evaluation of GAPs and GEFs Identifies a Targetable Dependency for Hematopoietic Malignancies
Cancer Discovery
December 2, 2025
Pu Zhang, Zhendong Cao, Xiangyu Pan, Yuqiao Liu, Cynthia Castro, Won Jun Kim, Takeshi Fujino, Jennifer Lewis, Jahan Rahman, Sanam Shahid,
et al.
OPM1,DSMZ,RRID:CVCL_5210
Human
: A549,
ATCC
,
CCL-185
Human
: A375,
ATCC
,
CRL-1619
Human
: AsPC1,
ATCC
,
CRL-1682
Human
: CfPAC1,
ATCC
,
CRL-1918
Human
: MA9.3-ITD,Laboratory of James C. Mulloy,N/A
Human
: MA9.3-RAS,Laboratory of James C. Mulloy,N/A Human:
(12)
KRAS/ABHD17C/ALOX15B Axis Promotes Pancreatic Cancer Progression via Ferroptosis Evasion
Advanced Science
September 1, 2025
Man Li, Xuexin Yu, Yuanji Liu, Shuqin Ouyang, Long Wu, Xiaohong Chen, Huiqi Yu, Haoming Chen, Senmao Lian, Ziwen Li,
et al.
(
CRL‐1682
),
BxPC‐3
(
CRL‐1687
),
HPAC
(
CRL‐2119
),
MIA PaCa‐2
(
CRM‐CRL‐1420
),
PANC‐1
(
CRL‐1469MET
), and CFPAC1 (
CRL‐1918
). The
PANC‐1
and CFPAC1 cells were maintained in DMEM (Invitrogen) containing 10% FBS. The HPAC, AsPC‐1,
(13)
A STAT3/integrin axis accelerates pancreatic cancer initiation and progression
Cell Reports
August 26, 2025
Alejandro D. Campos, Ryan M. Shepard, Zachary Ortega, Ingrid Heumann, Anna E. Wilke, Arin Nam, Carson Cable, Kourosh Kouhmareh, Richard Klemke, Nicole M. Mattson,
et al.
lines,
Experimental models
: Cell lines KP4,RIKEN BRC,RCB1005 KP2,JCRB Cell Bank,JCRB0181 CFPAC1,
ATCC
,
CRL-1918
; RRID: CVCL_1119 PANC1,
ATCC
,
CRL-1469
; RRID: CVCL_0480 COLO-357/FG (“FG”),Dr. Shama Kajiji and Vito
(14)
CAR-engineered lymphocyte persistence is governed by a FAS ligand–FAS autoregulatory circuit
Nature Cancer
July 22, 2025
Fei Yi, Tal Cohen, Natalie Zimmerman, Friederike Dündar, Paul Zumbo, Razan Eltilib, Erica J. Brophy, Hannah Arkin, Judith Feucht, Michael V. Gormally,
et al.
(Takara Bio, 631458), Nalm6 (ATCC, CRL-3273), JVM2 (ATCC, CRL-3002),
Raji
(
ATCC
,
CCL-86
),
CFPAC-1
(
ATCC
,
CRL-1918
), NCI-H441 (
ATCC
,
CRM-HTB-174
), SW-403 (
ATCC
,
CCL-230
), CL-40 (DSMZ, ACC 535), EFM-19 (DSMZ, ACC 231),
(15)
Inhibition of fatty acid binding protein suppresses pancreatic cancer progression and metastasis
Sci Rep
July 18, 2025
Shuhei Shinoda, Naohiko Nakamura, Kazuho Inoko, Mizuho Sato-Dahlman, Steven Carmella, Stephen Hecht, David A Bernlohr, Sayeed Ikramuddin, Masato Yamamoto
U.S). We also used
human
pancreatic cancer
cell lines;
PANC-1
(
CRL-1469
),
CAPAN-2
(
HTB-80
),
CFPAC-1
(
CRL-1918
), and
MIA PaCa-2
(
CRL-1420
,
ATCC
, Manassas, Virginia), and
human
gastrointestinal cancer
cell lines;
(16)
Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations
Cancer Discovery
July 3, 2025
Michelangelo Marasco, Dinesh Kumar, Santiago Garcia Garcia Borrego, Tessa Seale, Giulia Maddalena, Riccardo Mezzadra, Kylie Belanger, Soren Cole, Brayan Perez, Wei Luan,
et al.
different sources:
ATCC
(
MIA PaCa-2
/
CRL-1420
; RRID:CVCL_0428,
AsPC-1
/
CRL-1682
; RRID:CVCL_0152,
CFPAC-1
/
CRL-1918
; RRID:CVCL_1119, PANC02.13/
CRL-2554
; RRID:CVCL_1634, HS766.T/
HTB-134
; RRID:CVCL_0334,
HPAF-II
/
CRL-1997
;
(17)
Direct inhibition of RAS reveals the features of oncogenic signaling driven by RAS G12 and Q61 mutations
Cancer Discov
July 3, 2025
Michelangelo Marasco, Dinesh Kumar, Santiago Garcia Borrego, Tessa Seale, Giulia Maddalena, Riccardo Mezzadra, Kylie Belanger, Soren Cole, Brayan Perez, Wei Luan,
et al.
different sources:
ATCC
(
MIA PaCa-2
/
CRL-1420
; RRID:CVCL_0428,
AsPC-1
/
CRL-1682
; RRID:CVCL_0152,
CFPAC-1
/
CRL-1918
; RRID:CVCL_1119, PANC02.13/
CRL-2554
; RRID:CVCL_1634, HS766.T/
HTB-134
; RRID:CVCL_0334,
HPAF-II
/
CRL-1997
;
(18)
Cytosolic cytochrome c represses ferroptosis
Cell metabolism
June 3, 2025
Song X, Zhou Z, Liu J, Li J, Yu C, Zeh HJ, Klionsky DJ, Stockwell BR, Wang J, Kang R,
et al
.
Cente),N/A MEF,
ATCC
,
SCRC-1008
MEF cycs−/−,
ATCC
,
CRL-2613
Pfa1,Marcus Conrad (Helmholtz Munich),N/A CFPAC1,
ATCC
,
CRL-1918
Calu-1
,
ATCC
,
HTB-54
MC38,Sigma,SCC172 CX-1,National Institutes of Health,N/A
Experimental Models
:
(19)
METTL3 depletion blocks vesicular stomatitis virus replication in pancreatic cancer cells through the establishment of an intrinsic antiviral state
Journal of Virology
May 20, 2025
Cassandra Catacalos-Goad, Jacob Hawkins, Quinton Krueger, Nathaniel Foret, Valery Z. Grdzelishvili
and radiation,(39)
Capan-2
(
ATCC
:
HTB-80
),"1986, primary, male, 56 years",Chemo,(41)
CFPAC-1
(
ATCC
:
CRL-1918
),"1990,
metastasis
(liver), male, 26 years",N/A,(42) MIA PaCa-2,"1977, primary, male, 65 years",N/A,(43) SUIT-2,"1987,
(20)
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1
Elife
May 20, 2025
Jordina Rincon-Torroella, Marco Dal Molin, Brian Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs, Shun Ishiyama, Taha Ahmedna, Il Minn, Nilofer S Azad,
et al.
CRL-1682
, Cell line (H. sapiens),
BxPC-3
,
ATCC
,Cat #
CRL-1687
, Cell line (H. sapiens),
CFPAC-1
,
ATCC
,Cat #
CRL-1918
, Cell line (H. sapiens),
DLD-1
,
ATCC
,Cat #
CCL-21
, Cell line (H. sapiens),
MIA PaCa-2
MCT1
KO,This study,N/A, Cell
Page
<<
<
1
2
3
4
5
>
>>
Reviews
Be the First to Write a Review!
CFPAC-1 from ATCC
Supplier Page
View Company Product Page
$431.00
Product Specs
Company Info
Citations
Reviews
Back To Top